Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 26, 2019
[ Tue, Mar 26th 2019
] - WOPRAI
[ Tue, Mar 26th 2019
] - WOPRAI
[ Tue, Mar 26th 2019
] - WOPRAI
[ Tue, Mar 26th 2019
] - WOPRAI
[ Tue, Mar 26th 2019
] - WOPRAI
[ Tue, Mar 26th 2019
] - WOPRAI
Mon, March 25, 2019
[ Mon, Mar 25th 2019
] - WOPRAI
[ Mon, Mar 25th 2019
] - WOPRAI
[ Mon, Mar 25th 2019
] - WOPRAI
[ Mon, Mar 25th 2019
] - WOPRAI
[ Mon, Mar 25th 2019
] - WOPRAI
[ Mon, Mar 25th 2019
] - WOPRAI
Fri, March 22, 2019
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
[ Fri, Mar 22nd 2019
] - WOPRAI
Carter Gould Downgraded (BIIB) to Hold on, Mar 22nd, 2019
Carter Gould of UBS, Downgraded "Biogen Inc." (BIIB) to Hold on, Mar 22nd, 2019.
Carter has made no other calls on BIIB in the last 4 months.
There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, all agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Alethia Young of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Matt Phipps of "William Blair" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
- Ian Somaiya of "BMO Capital" Initiated at Hold and Held Target at $322 on, Friday, February 22nd, 2019
- Adnan Butt of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $325 on, Friday, February 22nd, 2019
- Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019
